Clinical and pharmaceutical success from discovery to regulatory approval: biomarkers, modeling and analytical technologies.

Autor: Zhang TT; No.13 Building, 67 Libing Road, Zhangjiang Hi-Tech Park, Shanghai, China 201203, PR China., Weng N; Janssen, Pharmaceutical companies of Johnson & Johnson, 1400 McKean Road, Spring House, PA 19477, USA., Lee M; Milestone Development Services, 7 Snowdrop Place, Newtown, PA 18940, USA.
Jazyk: angličtina
Zdroj: Bioanalysis [Bioanalysis] 2017 Oct; Vol. 9 (19), pp. 1437-1440. Date of Electronic Publication: 2017 Oct 21.
DOI: 10.4155/bio-2017-4978
Abstrakt: The 8th Annual Shanghai Symposium on Clinical and Pharmaceutical Solutions through Analysis (CPSA): Clinical and Pharmaceutical Success from Discovery to Regulatory Approval: Biomarkers, Modeling and Analytical Technologies (CPSA Shanghai 2017); Renaissance Shanghai Pudong Hotel, Shanghai, China, 12-14 April 2017 was held on 12-14 April 2017 in Shanghai, China. The meeting was featured with highly interactive events including diversified symposia, workshops, roundtable discussions, conference awards and poster sessions. There were over 220 participants with 61 oral presentations and 20 posters presented. In addition, the meeting included a preconference workshop with an inaugural session on the evaluation of quality and efficacy for generic drugs in China.
Databáze: MEDLINE